PARAMOUNT: Descriptive subgroup analyses of final overall survival for the phase iii study of maintenance pemetrexed versus placebo following induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer

  1. Reck, M.
  2. Paz-Ares, L.G.
  3. De Marinis, F.
  4. Molinier, O.
  5. Sahoo, T.P.
  6. Laack, E.
  7. John, W.
  8. Zimmermann, A.H.
  9. Visseren-Grul, C.
  10. Gridelli, C.
Aldizkaria:
Journal of Thoracic Oncology

ISSN: 1556-0864,  1556-1380

Argitalpen urtea: 2014

Alea: 9

Zenbakia: 2

Orrialdeak: 205-213

Mota: Artikulua

DOI: 10.1097/JTO.0000000000000076 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus